Neogen Corporation's sizeable $11 billion food-and-animal safety TAM still has secular tailwinds with regulation, traceability, and disease-prevention trends. Management believes this market has an overall projected 6%–7% CAGR through 2030. In that context, NEOG's Petrifilm anchors future recurring consumables and end-to-end testing ecosystem.

Neogen Corporation (NASDAQ: NEOG) on Wednesday initiated a voluntary nationwide recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium Sterile Solution. The company identified microbial contamination in certain batches.

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.

Neogen Corporation (NASDAQ: NEOG - Get Free Report) shares saw an uptick in trading volume on Friday. 4,702,857 shares changed hands during trading, a decline of 6% from the previous session's volume of 5,004,718 shares.The stock last traded at $9.9060 and had previously closed at $9.93. Analyst Ratings Changes A number of equities analysts have

Nisa Investment Advisors LLC lowered its position in shares of Neogen Corporation (NASDAQ: NEOG) by 79.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,884 shares of the company's stock after selling 102,152 shares during the period. Nisa Investment Advisors LLC's holdings

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

Shares of Neogen Corporation (NASDAQ: NEOG - Get Free Report) were down 5.5% during trading on Friday. The company traded as low as $8.44 and last traded at $9.1790. Approximately 1,803,973 shares traded hands during trading, a decline of 71% from the average daily volume of 6,287,906 shares. The stock had previously closed at $9.71.

The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly year-over-year.

Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.